Secondary Logo

Journal Logo

Articles by JoAnn V. Pinkerton

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review

Simon, James A.; Goldstein, Irwin; Kim, Noel N.; More

Menopause. 25(7):837-847, July 2018.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

Pinkerton, JoAnn V.; Constantine, Ginger; Hwang, Eunhee; More

Menopause: The Journal of The North American Menopause Society. 20(1):28-37, January 2013.

Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial

Pinkerton, JoAnn V.; Archer, David F.; Guico-Pabia, Christine J.; More

Menopause: The Journal of The North American Menopause Society. 20(1):38-46, January 2013.

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause

Archer, David F.; Pinkerton, JoAnn V.; Guico-Pabia, Christine J.; More

Menopause: The Journal of The North American Menopause Society. 20(1):47-56, January 2013.

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development

Pinkerton, JoAnn V.; Goldstein, Steven R.

Menopause. 17(3):642-653, May-June 2010.

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

Pinkerton, JoAnn V.; Archer, David F.; Utian, Wulf H.; More

Menopause. 16(6):1102-1108, November-December 2009.

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

Archer, David F.; Pinkerton, JoAnn V.; Utian, Wulf H.; More

Menopause. 16(6):1109-1115, November-December 2009.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

Pinkerton, JoAnn V.; Utian, Wulf H.; Constantine, Ginger D.; More

Menopause. 16(6):1116-1124, November-December 2009.

Show: